Piramal Pharma Ltd. (PPLPHARMA) Share Price Hits Fresh 52-Week High

Piramal Pharma Ltd. Share Price rose 1.41% to Rs 219.55, hit a fresh 52-week high of Rs 220.40 and took market capitalisation to Rs 27,898.40 crore.

Piramal Pharma Ltd. Share Price was at Rs 219.55 on 21 August 2026 at 9:22 AM IST, up Rs 3.05 or 1.41% from the previous close of Rs 216.50, after touching a fresh 52-week high of Rs 220.40. The company’s market capitalisation stood at Rs 27,898.40 crore, putting the stock firmly on the radar in today’s market action.

This Piramal Pharma Ltd. Share Price move matters because a new 52-week high often draws attention from traders tracking momentum and from investors screening for relative strength across the Indian stock market. In this case, the verified data confirms the one-year high and the intraday advance, but it does not establish a company-specific catalyst behind the move.

For readers following Piramal Pharma Ltd. Stock News, the immediate story is straightforward: the stock opened at Rs 217.05, traded between Rs 216.00 and Rs 220.40, and generated turnover of Rs 1.71 crore on volume of 77,905 shares. That combination makes Piramal Pharma Ltd. Share Price Today relevant not only as a headline move but also as a data point for stock analysis, valuation review and sector comparison. Univest examines the price action first, then the broader fundamental and healthcare-sector context around this fresh 52-week peak.

Piramal Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 219.55
Previous Close	Rs 216.5
Today's Change	+Rs 3.05 (+1.41%)
Day Open	Rs 217.05
Fresh 52-Week High	Rs 220.4
Day Low	Rs 216
Current Volume	77,905
Turnover	Rs 1.71 crore
Market Capitalisation	Rs 27,898.4 crore

Piramal Pharma Ltd. (PPLPHARMA) traded at Rs 219.55. versus the previous close of Rs 216.5, a rise of 1.41%. The stock opened at Rs 217.05, reached Rs 220.4, touched Rs 216. Reported volume was 77,905.

Piramal Pharma Ltd. Share Price Today shows a measured but clear breakout session, with the stock rising from Rs 216.50 to Rs 219.55 and setting a fresh 52-week high at Rs 220.40. The intraday range, turnover and traded volume confirm that the stock is attracting attention in today’s market update.

The stock began the session at Rs 217.05, slightly above the previous close of Rs 216.50, indicating firm opening demand. Through the session it moved within a Rs 4.40 band between the day’s low of Rs 216.00 and the day’s high of Rs 220.40. By the time the event was recorded at 9:22:14 AM IST, Piramal Pharma Ltd. Share Price had gained Rs 3.05, or 1.41%, and was holding close to the session high.

That is the core of the Piramal Pharma Ltd. Share Price Update: the stock did not merely rise on an isolated print, it traded up to a new yearly high and stayed elevated relative to the prior close. Turnover of Rs 1.71 crore and volume of 77,905 shares also show that the move came with visible market participation, which is why the stock is appearing in screens such as 52 Week High Stocks and Stocks in News.

For investors looking at Piramal Pharma Ltd. Share News and broader price action, the supplied data confirms momentum in the near term but stops short of identifying a verified business trigger. That makes the next layer of analysis important: whether the fundamentals and valuation context justify continued investor attention at this 52-week peak.

Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 27,898.4 crore
P/E Ratio	50.55x
P/B Ratio	1.94x
ROE	-0.78%
ROCE	8.31%

Piramal Pharma Ltd. was valued at a P/E ratio of 50.55x, a P/B ratio of 1.94x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	50.55x
Benchmark Median P/E	21.42x
Benchmark Average P/E	48.98x
Benchmark P/E Range	0x to 1,614.49x
Company P/B Ratio	1.94x
Benchmark Median P/B	1.94x
Company ROE	-0.78%
Benchmark Median ROE	11.09%
Company ROCE	8.31%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 27,898.4 crore
Benchmark Median Market Cap	Rs 132.66 crore

Piramal Pharma Ltd. (PPLPHARMA) is classified under sector: Healthcare.

Piramal Pharma Ltd. (PPLPHARMA) has a P/E ratio of 50.55x, which is above the benchmark median of 21.42x, a difference of +135.99%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,803.21	50.55	1.94	-0.78	8.31
Dishman Carbogen Amcis Ltd.	DCAL	2,700.59	166.73	0.41	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,668.21	61.53	9.73	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,566.23	33.67	6.94	36.29	42.4
Sai Parenteral's Ltd.	SAIPARENT	2,386.78	142.94	3.09	13.9	12.97

Piramal Pharma Ltd. (PPLPHARMA) has a P/E ratio of 50.55x compared with the displayed peer median of 61.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 27,898.4 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Piramal Pharma Ltd.

Piramal Pharma Ltd. is being watched because the stock has hit a fresh 52-week high while trading near the day’s top end. The price move, valuation profile and scale relative to the supplied healthcare universe together make this a relevant stock news event.

• Fresh yearly high: the stock touched Rs 220.40, marking a new 52-week peak.
• Positive session: Piramal Pharma Ltd. Share Price was up Rs 3.05 or 1.41% from Rs 216.50 to Rs 219.55.
• Active trading: turnover stood at Rs 1.71 crore with volume of 77,905 shares.
• Large scale: market capitalisation of Rs 27,898.40 crore is far above the supplied sector benchmark distribution.
• Valuation context: P/E of 50.55 is above the sector median of 21.42 and slightly above the average of 48.98.
• Profitability watchpoint: ROE of -0.78% and ROCE of 8.31% are below sector medians of 11.09% and 13.29%.

About Piramal Pharma Ltd.

The supplied data identifies Piramal Pharma Ltd. as part of the Healthcare sector. In the comparison sets provided, most relevant listed peers fall under Pharmaceuticals & Drugs, while one peer, Dr Agarwals Eye Hospital Ltd., sits in Hospital & Healthcare Services. That places Piramal Pharma Ltd. within a broad healthcare investing universe where valuations and return ratios can vary significantly across business models.

Because the verified dataset for this article is event-led, the clearest company context available today is its market presence through scale. With a market capitalisation of Rs 27,898.40 crore, Piramal Pharma Ltd. stands well above the market-cap figures shown in the supplied benchmark and peer snapshots. For readers following Piramal Pharma Ltd. Company News and Piramal Pharma Ltd. Shareholding Pattern searches, today’s article is focused on the confirmed 52-week high event, price action and financial ratio context available from verified screener data. Univest will typically see investors use this type of snapshot to place a stock in context before tracking future financial results, valuation shifts and sector-relative performance.

Track Piramal Pharma Ltd. Share Price on Univest

Use Piramal Pharma Ltd. (PPLPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Piramal Pharma Ltd. Share Price can be tracked on Univest for live share price moves, 52-week levels, market-cap changes and key valuation ratios. For readers following Piramal Pharma Ltd. Share Price Live, Piramal Pharma Ltd. News Today and Piramal Pharma Ltd. Stock Performance, Univest helps organise price action with broader market insights in one place.

As this fresh one-year high shows, a stock can attract attention quickly when it appears in Market News screens and broader Stock Market Today conversations. Tracking Piramal Pharma Ltd. Share Price on Univest can help investors monitor whether the stock sustains attention after this 52-week peak, how valuation compares with peers, and how the healthcare benchmark evolves around it, without turning a market update into a recommendation.

Frequently Asked Questions

What is the latest Piramal Pharma Ltd. Share Price Today?

Ans. Piramal Pharma Ltd. Share Price Today was Rs 219.55 at the time of the event. The stock was up Rs 3.05, or 1.41%, from the previous close of Rs 216.50 during the 21 August 2026 session.

Did Piramal Pharma Ltd. hit a fresh 52-week high?

Ans. Yes, Piramal Pharma Ltd. hit a fresh 52-week high of Rs 220.40. The stock later traded at Rs 219.55, which kept it close to the day’s peak and highlighted strong market attention in the session.

Why is Piramal Pharma Ltd. rising today?

Ans. The verified data confirms that the stock rose 1.41% and touched a new 52-week high. However, the supplied data set establishes the price event and trading activity only, not a company-specific catalyst for the move.

What do today’s price action numbers show for Piramal Pharma Ltd.?

Ans. The stock opened at Rs 217.05, fell to a low of Rs 216.00 and rose to Rs 220.40 before trading at Rs 219.55. That intraday pattern shows firm upward price movement during the session.

How much trading activity was seen in Piramal Pharma Ltd. today?

Ans. Piramal Pharma Ltd. recorded volume of 77,905 shares and turnover of Rs 1.71 crore in the reported session. Those figures confirm active participation as the stock moved to a fresh one-year high.

What is the market capitalisation of Piramal Pharma Ltd.?

Ans. Piramal Pharma Ltd. had a market capitalisation of Rs 27,898.40 crore in the supplied data. That makes it substantially larger than the market-cap figures shown in the provided healthcare sector benchmark snapshot.

Is Piramal Pharma Ltd. expensive compared with the healthcare benchmark?

Ans. On earnings valuation, the stock’s P/E of 50.55 is above the sector median of 21.42 and slightly above the sector average of 48.98. Its P/B of 1.94, however, exactly matches the benchmark median.

How do Piramal Pharma Ltd. profitability ratios compare with the sector?

Ans. The company’s ROE is -0.78% and ROCE is 8.31%. Both are below the healthcare benchmark medians of 11.09% for ROE and 13.29% for ROCE in the supplied sector comparison snapshot.

How does Piramal Pharma Ltd. compare with selected peers?

Ans. Compared with peers, Piramal Pharma Ltd. has a P/E lower than Dishman Carbogen Amcis and Sai Parenteral's, but higher than Dr Agarwals Eye Hospital. Its ROE and ROCE trail several peers with stronger reported returns.

What should investors monitor next in Piramal Pharma Ltd. Stock News?

Ans. Investors may watch whether Piramal Pharma Ltd. Share Price holds near the fresh 52-week peak, how valuation changes against healthcare peers, and whether future company financials improve on ROE and ROCE from current levels.